Your browser doesn't support javascript.
loading
Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.
Coveney, Clarissa; Tellier, Michel; Lu, Fangfang; Maleki-Toyserkani, Shayda; Jones, Ruth; Bart, Valentina M T; Pring, Ellie; Alrubayyi, Aljawharah; Richter, Felix C; Scourfield, D Oliver; Rehwinkel, Jan; Rodrigues, Patrícia R S; Davies, Luke C; Gea-Mallorquí, Ester.
Afiliação
  • Coveney C; Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
  • Tellier M; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Lu F; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Maleki-Toyserkani S; Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Jones R; Dementia Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Bart VMT; Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Pring E; Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Alrubayyi A; Viral Immunology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Richter FC; Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
  • Scourfield DO; Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Rehwinkel J; Medical Research Council Human Immunology Unit, Radcliffe Department of Medicine, Medical Research Council Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Rodrigues PRS; Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Davies LC; Systems Immunity Research Institute, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Gea-Mallorquí E; Viral Immunology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxf Open Immunol ; 1(1): iqaa004, 2020.
Article em En | MEDLINE | ID: mdl-34192267
ABSTRACT
The coronavirus infectious disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a world health concern and can cause severe disease and high mortality in susceptible groups. While vaccines offer a chance to treat disease, prophylactic and anti-viral treatments are still of vital importance, especially in context of the mutative ability of this group of viruses. Therefore, it is essential to elucidate the molecular mechanisms of viral entry, innate sensing and immune evasion of SARS-CoV-2, which control the triggers of the subsequent excessive inflammatory response. Viral evasion strategies directly target anti-viral immunity, counteracting host restriction factors and hijacking signalling pathways to interfere with interferon production. In Part I of this review, we examine SARS-CoV-2 viral entry and the described immune evasion mechanisms to provide a perspective on how the failure in initial viral sensing by infected cells can lead to immune dysregulation causing fatal COVID-19, discussed in Part II.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article